Opana Approval History
FDA Approved: Yes (First approved June 22, 2006)
Brand name: Opana
Generic name: oxymorphone
Dosage form: Tablets and ER Tablets
Company: Endo Pharmaceuticals Inc.
Treatment for: Pain
Opana ER (extended-release) and Opana (immediate-release) are oral formulations of the opioid analgesic oxymorphone, used for the relief of moderate-to-severe pain. Opana ER is indicated for patients requiring continuous, around-the-clock opioid treatment for an extended period of time, and Opana is indicated for the relief of acute pain where the use of an opioid is appropriate.